Top
search
Home
About Us
Subject
Browse
0
Sign In
Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
Twitter
Facebook
WhatsApp
LinkedIn
link
Copy URL
Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
×
Bookmark
Name
*
Name should not be blank
Label
Labeling your bookmark will be stored as a collection in My Research
Citation
×
Citation Format
APA
APA
MLA
Chicago
Harvard
Mandeley
RIS
Text
BibTex
Vancouver
EndNote
Copy to clipboard
Open Citations
Mendeley
ReadCube
Export
Experimental Dermatology
Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
DOI:
10.1111/exd.14352, Issue: null, Pages: 0-0
Article Type:
letter,
Article History
rev-recd:
2021-4-4
received:
2020-10-21
accepted:
2021-4-6
published:
2021-5-4
XML
KUDOS
Twitter
Facebook
WhatsApp
LinkedIn
link
Copy URL
Altmetric
Highlights
Notes
Recommended articles
Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention
Experimental Dermatology
Induction of IL‐1β and antimicrobial peptides as a potential mechanism for topical dithranol
Experimental Dermatology
Does autoimmune vitiligo protect against COVID‐19 disease?
Experimental Dermatology
A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID‐19) who developed virus or drug‐related mucocutaneous manifestations
Experimental Dermatology
Anti‐COVID‐19 measurements for hidradenitis suppurativa patients
Experimental Dermatology
Citing articles via
Crossref
Google Scholar
Science Open
Scopus
Web of Science
Within ResearchPad
RePEc
Tweets
Follow
Tweets by ResearchPad
Tweet to @ResearchPad
Follow us in facebook
×
×
×
×
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.1111/exd.14352&title=Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients&author=&keyword=&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy
| Powered by:
Nova